Application of Umbilical Cord Blood Derived Stem Cells in Diseases of the Nervous System

Bhagelu R Achyut, Nadimpalli Ravi S Varma, Ali S Arbab

Research output: Contribution to journalArticle

Abstract

Umbilical cord blood (UCB) derived multipotent stem cells are capable of giving rise hematopoietic, epithelial, endothelial and neural progenitor cells. Thus suggested to significantly improve graft-versus-host disease and represent the distinctive therapeutic option for several malignant and non-malignant diseases. Recent advances in strategies to isolate, expand and shorten the timing of UCB stem cells engraftment have tremendously improved the efficacy of transplantations. Nervous system has limited regenerative potential in disease conditions such as cancer, neurodegeneration, stroke, and several neural injuries. This review focuses on application of UCB derived stem/progenitor cells in aforementioned pathological conditions. We have discussed the possible attempts to make use of UCB therapies to generate neural cells and tissues with developmental and functional similarities to neuronal cells. In addition, emerging applications of UCB derived AC133+ (CD133+) endothelial progenitor cells (EPCs) as imaging probe, regenerative agent, and gene delivery vehicle are mentioned that will further improve the understanding of use of UCB cells in therapeutic modalities. However, safe and effective protocols for cell transplantations are still required for therapeutic efficacy.

Original languageEnglish (US)
JournalJournal of stem cell research & therapy
Volume4
DOIs
StatePublished - Jan 20 2015
Externally publishedYes

Fingerprint Dive into the research topics of 'Application of Umbilical Cord Blood Derived Stem Cells in Diseases of the Nervous System'. Together they form a unique fingerprint.

  • Cite this